This study is testing a pill called IMP4297 to see if it can help keep ovarian cancer from returning after patients finish their first round of chemotherapy. It involves 404 women with advanced ovarian cancer who responded well to initial chemo. Participants are randomly assigned…
Phase: PHASE3 • Sponsor: Impact Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC